This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Shenzhen Targetrx, Inc.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: The Innovations of Jian Jin
Introduction
Jian Jin is a notable inventor based in Guangdong, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit protein tyrosine kinase activity. His work is crucial in addressing various diseases, including cancers and immune disorders.
Latest Patents
Jian Jin holds a patent for an amino pyrimidine compound designed to inhibit protein tyrosine kinase activity. This patent includes a pharmaceutical composition, preparation methods, and applications of the compound. The compound is represented by a specific formula, with various components defined in the specification. It can be utilized for treating and preventing protein tyrosine kinase-related diseases, such as cell proliferative diseases and cancers.
Career Highlights
Jian Jin is currently associated with Shenzhen Targetrx, Inc., where he continues to innovate in the pharmaceutical sector. His expertise in developing therapeutic compounds has positioned him as a valuable asset in his field.
Collaborations
Jian Jin collaborates with talented individuals such as Yihan Wang and Xingye Ren, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Jian Jin's work exemplifies the impact of innovative research in the pharmaceutical industry. His contributions are vital for advancing treatments for serious health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile